HIV/AIDS STILL DESERVES THE FUNDING IT GETS!
What does a disease deserve? Jocelyn Kaiser Pressure from AIDS groups such as ACT UP, protesting at the White House in 1987, propelled Congress to begin earmarking research funding for HIV/AIDS. PHOTO: © BETTMANN/CORBIS In the early 1990s, as the deadly HIV/AIDS epidemic marched across the United States and the world, lawmakers in Congress and top officials at the National Institutes of Health (NIH) reached an unusual understanding: Roughly 10% of the NIH budget would be dedicated to fighting the devastating disease. Since then, the steady flow of research cash—some $3 billion this year—has helped transform HIV infection from a death sentence to a manageable disease for many people, and some researchers believe they are getting closer to developing a vaccine that could halt new infections. That special arrangement is now under fire. Health policy experts, lawmakers, and even NIH officials have wondered why, 2 decades after AIDS death rates began dropping dr...